Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: Pooled analyses of the ReSTORE and STRIVE randomised trials

Authors

• Patrick M Honoré, UCL Louvain Medical School
• Massimo Girardis, University of Modena and Reggio Emilia
• Marin Kollef, Washington University School of Medicine in St. Louis
• Oliver A Cornely, University of Cologne
• George R Thompson III, University of California, Davis
• Matteo Bassetti, University of Genoa
• Alex Soriano, University of Barcelona
• Haihui Huang, Fudan University
• Jose Vazquez, Medical College of Georgia
• Bart Jan Kullberg, Radboud University
• Peter G Pappas, University of Alabama at Birmingham
• Nick Manamley, Mundipharma Research Ltd
• Taylor Sandison, Cidara Therapeutics, Inc.
• John Pullman, Mercury Street Medical
• Saad Nseir, Université de Lille

Journal

Critical care

Publication Date

10-28-2024

Volume

28

Issue

1

First Page

348

Document Type

Open Access Publication

DOI

10.1186/s13054-024-05117-5

Rights and Permissions

Honoré, P.M., Girardis, M., Kollef, M. et al. Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials. Crit Care 28, 348 (2024). https://doi.org/10.1186/s13054-024-05117-5 This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Recommended Citation

Honoré, Patrick M; Girardis, Massimo; Kollef, Marin; Cornely, Oliver A; Thompson, George R III; Bassetti, Matteo; Soriano, Alex; Huang, Haihui; Vazquez, Jose; Kullberg, Bart Jan; Pappas, Peter G; Manamley, Nick; Sandison, Taylor; Pullman, John; and Nseir, Saad, "Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: Pooled analyses of the ReSTORE and STRIVE randomised trials." Critical care. 28, 1. 348 (2024).
https://digitalcommons.wustl.edu/oa_4/6657

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.